Neuregulin-1 reduces necroptosis and protects mice from death caused by respiratory viral infection

---

Presentation Time: 01:45 PM - 02:00 PM
Abstract ID: 4494 - A

Presenting Author:
Syed-Rehan A Hussain , Research Scientist at Wexner Res. Inst., Nationwide Childrens Hosp.

Abstract:

Respiratory syncytial virus (RSV) and influenza type A virus (IAV) cause significant morbidity and mortality even with available vaccines. Pre-existing atopy provides protection against death in mice infected with Sendai virus (SeV), a rodent virus related to RSV. We found neuregulin-1 (NRG1) expressed at high levels in atopic mice, and when given exogenously (500 ng/day i.n for five days) to non-atopic mice provides significant protection against mortality from lethal doses of both SeV (2x10⁶ pfu) and IAV (3x10³ pfu PR8-mouse adapted). Further, using well-differentiated human airway epithelial cells, NRG-1 was found to improve epithelial barrier function following RSV infection. RSV has been reported to cause necroptosis, which can induce inflammation and alter epithelial membrane permeability. We hypothesized the survival advantage of NRG1 involves inhibition of necroptosis. Treating cells from the murine airway epithelial cell line LET-1 with NRG1 before inoculation with SeV significantly inhibited viral induced necroptosis as measured by a real-time non-lytic apoptosis/necroptosis assay. Furthermore, NRG1 reduced expression of genes promoting necroptosis (RIPK3 and MLKL) in well-differentiated human bronchial epithelial cells 72h post RSV infection. Together, these data suggest NRG1 modulates viral induced cell death through inhibition of necroptosis of epithelial cells and may explain the reduced airway leak and increased survival seen in our model.